Skip to main content

Table 1 Selected indicator conditions, associated specialties, and specific selection criteria for eligibility

From: Promoting HIV indicator condition-guided testing in hospital settings (PROTEST 2.0): study protocol for a multicentre interventional study

Indicator condition Main Specialty Indicator condition-specific selection criteria
Tuberculosis Pulmonology Patients with latent M. tuberculosis infection, but no tuberculosis disease, are excluded
Cervical cancer or CIN 3+ Gynaecology Patients without biopsy-confirmed high-grade dysplasia (CIN 3+) or carcinoma (invasive or non-invasive) are excluded
Vulvar cancer or VIN 3+ Gynaecology Patients without biopsy-confirmed high-grade dysplasia (VIN 3+) or carcinoma (invasive or non-invasive) are excluded
Malignant lymphoma Haematology All types of malignant lymphoma, including all subtypes of Hodgkin’s lymphoma and non-Hodgkin lymphoma are included
Hepatitis B Gastroenterology Both acute and chronic hepatitis B cases are included
Hepatitis C Gastroenterology Both acute and chronic hepatitis C cases are included
Peripheral neuropathy Neurology Patients with known diabetes mellitus before presenting and patients for whom no diagnostic laboratory workup was indicated are excluded
  1. CIN cervical intraepithelial neoplasia, VIN vulvar intraepithelial neoplasia